BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2169360)

  • 1. Inositol phospholipid turnover and intracellular Ca2+ responses to thyrotrophin-releasing hormone, gonadotrophin-releasing hormone and arginine vasopressin in pituitary corticotroph and somatotroph adenomas.
    Levy A; Lightman SL; Hoyland J; Mason WT
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):73-9. PubMed ID: 2169360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of thyrotropin-releasing hormone and gonadotropin-releasing hormone on inositol phospholipid turnover in endocrinologically inactive pituitary adenomas and prolactinomas.
    Levy A; Lightman SL
    J Clin Endocrinol Metab; 1989 Jul; 69(1):122-6. PubMed ID: 2543687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary adenomas with high and low basal inositol phospholipid turnover; the stimulatory effect of kinins and an association with interleukin-6 secretion.
    Jones TH; Kennedy RL; Justice SK; Price A
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):433-9. PubMed ID: 8287569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gonadotropin-releasing hormone (GnRH) antagonist distinguishes three populations of GnRH analog-responsive cells in human and rat pituitary in vitro and produces an acute increase in intracellular Ca2+ concentration without inducing gonadotropin secretion.
    Levy A; Lightman SL; Hoyland J; Rawlings S; Mason WT
    Mol Endocrinol; 1990 May; 4(5):678-84. PubMed ID: 2177142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal nitric oxide synthase gene expression in human pituitary tumours: a possible association with somatotroph adenomas and growth hormone-releasing hormone gene expression.
    Ueta Y; Levy A; Powell MP; Lightman SL; Kinoshita Y; Yokota A; Shibuya I; Yamashita H
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):29-38. PubMed ID: 9797844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular calcium ion responses to somatostatin in cells from human somatotroph adenomas.
    Chen ZP; Xu S; Lightman SL; Hall L; Levy A
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):45-53. PubMed ID: 9059557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic peptides modulate cytosolic free Ca2+ levels and adenylyl cyclase activity in human nonfunctioning pituitary adenomas.
    Spada A; Reza-Elahi F; Lania A; Gil-del-Alamo P; Bassetti M; Faglia G
    J Clin Endocrinol Metab; 1991 Oct; 73(4):913-8. PubMed ID: 1679762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoprotein hormone alpha-subunit production and plurihormonality in human corticotroph tumours--an in vitro and immunohistochemical study.
    Desai B; Burrin JM; Nott CA; Geddes JF; Lamb EJ; Aylwin SJ; Wood DF; Thakkar C; Monson JP
    Eur J Endocrinol; 1995 Jul; 133(1):25-32. PubMed ID: 7542980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas.
    Kim K; Arai K; Sanno N; Teramoto A; Shibasaki T
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):309-16. PubMed ID: 11298082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of a gonadotrophin-releasing hormone agonist ([D-Ser(But)6]GnRH(1-9)nonapeptide-ethylamide) on gonadotrophin secretion from human pituitary gonadotroph cell adenomas in vitro.
    Daniels M; Newland P; Dunn J; Kendall-Taylor P; White MC
    J Endocrinol; 1988 Sep; 118(3):491-6. PubMed ID: 2460576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
    Kola B; Korbonits M; Diaz-Cano S; Kaltsas G; Morris DG; Jordan S; Metherell L; Powell M; Czirják S; Arnaldi G; Bustin S; Boscaro M; Mantero F; Grossman AB
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):328-38. PubMed ID: 12919156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of alpha-subunit of glycoprotein hormones by pituitary somatotroph adenomas in vitro.
    Kontogeorgos G; Asa SL; Kovacs K; Smyth HS; Singer W
    Acta Endocrinol (Copenh); 1993 Dec; 129(6):565-72. PubMed ID: 7509101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary adenomas of patients with acromegaly express thyrotropin-releasing hormone receptor messenger RNA: cloning and functional expression of the human thyrotropin-releasing hormone receptor gene.
    Yamada M; Monden T; Satoh T; Satoh N; Murakami M; Iriuchijima T; Kakegawa T; Mori M
    Biochem Biophys Res Commun; 1993 Sep; 195(2):737-45. PubMed ID: 8396925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotrophin-Releasing Hormone Raises Cytosolic Free Calcium Concentration in Human Adenomatous Somatotrophs and Corticotrophs; Comparison with in vivo Responsiveness to Thyrotrophin-Releasing Hormone in Patients with Acromegaly or Cushing's Disease.
    Spada A; Reza-Elahi F; Lania A; Pandiella A; Bassetti M; Bazzoni N; Alamo PG; Faglia G
    J Neuroendocrinol; 1991 Feb; 3(1):51-6. PubMed ID: 19215446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phorbol ester, not growth hormone releasing factor, consistently stimulates growth hormone release from somatotroph adenomas in culture.
    Emoto N; Ohmura E; Isozaki O; Tsushima T; Shizume K; Demura H
    Clin Endocrinol (Oxf); 1991 May; 34(5):377-82. PubMed ID: 2060147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma.
    Gil-del-Alamo P; Pettersson KS; Saccomanno K; Spada A; Faglia G; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):661-6. PubMed ID: 7828356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenylate cyclase of GH and ACTH producing tumors of human: activation by non-specific hormones and other bioactive substances.
    Matsukura S; Kakita T; Hirata Y; Yoshimi H; Fukase M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):392-7. PubMed ID: 190256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone-releasing hexapeptide (GHRP-6) increases intracellular calcium concentrations in cultured cells from human pituitary adenomas of different types.
    Lania A; Ballaré E; Corbetta S; Filopanti M; Persani L; Spada A
    Eur J Endocrinol; 1998 Sep; 139(3):343-8. PubMed ID: 9758447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.